Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3454)
All Articles published online
|
Publishing Process of This Article
|
Sep 15, 2024 (publication date) through May 6, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Qureshi W, Dar MA, Rather MY. New therapy for metabolic syndrome: Gut microbiome supplementation. World J Diabetes 2024; 15(9): 1833-1836 [PMID: 39280175 DOI: 10.4239/wjd.v15.i9.1833] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Qureshi W, Dar MA, Rather MY. New therapy for metabolic syndrome: Gut microbiome supplementation. World J Diabetes 2024; 15(9): 1833-1836 [PMID: 39280175 DOI: 10.4239/wjd.v15.i9.1833] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v15/i9/1833.htm |
| Number | Citing Articles |
| 1 |
Sania Ansari, Ketan J. Purohit, Ajay B. Shelke, Mahek Shah, Innocent Adamson Nkhoma, Archana M. Navale, Rutika Wakchaure. Microbiota-driven mechanisms in multisystem diseases: integrative evidence across cardiovascular, metabolic, neurological and autoimmune disorders. Antonie van Leeuwenhoek 2026; 119(5) doi: 10.1007/s10482-026-02296-9
|
| 2 |
Xiaoyan Cui, Qianwen Yuan, Jiali Long, Jiaxin Zhou. Recent advances in gut microbiota-mediated regulation of fat deposition and metabolic disorders. Microbiome Research Reports 2025; 4(3) doi: 10.20517/mrr.2025.25
|
| 3 |
Mustafa Al Jnainati, Aishwarya Govindarajan, Srishti Tyagi, Muhammad Iltaf, Jana Al Jnainati, Mohammad Ayoub, Hooria Aiman Shadab. Harnessing Microbiome Therapy to Treat Metabolic Syndrome. AACE Endocrinology and Diabetes 2026; doi: 10.1016/j.aed.2025.11.015
|
| 4 |
Xin Chang, Rui-Feng Mao, Hong-Juan Wei, Jin Wang. Gut microbiota modulating therapy for diabetes mellitus should be individualized. World Journal of Diabetes 2024; 15(10): 2152-2156 doi: 10.4239/wjd.v15.i10.2152
|
| 5 |
Rupali Chauhan, Khemender Lidoo, Uma Jyoti, Thakur Gurjeet Singh, Sushma Devi. Decoding the gut microbiota-mitochondrial-inflammasome axis in cardiovascular disease. Molecular and Cellular Biochemistry 2025; 481(3): 1081 doi: 10.1007/s11010-025-05451-4
|
| 6 |
Emili Bruna Toso Bueno, Kimberlly de Oliveira Silva, Maria Eduarda Ferraz Mendes, Lívia Batista de Oliveira, Felipe Prado de Menezes, Anna Cardoso Imperador, Lucimeire Fernandes Correia, Lizziane Kretli Winkelstroter. Postbiotics Derived from Lactic Acid Bacteria Fermentation: Therapeutic Potential in the Treatment of Muscular Complications in Inflammatory Bowel Disease. Fermentation 2025; 11(7): 362 doi: 10.3390/fermentation11070362
|
| 7 |
Subhash Pandian, Meenakshi Reddy Yathindra, Vanksha Shrivastava, Yuliya Prystupa. The gut-vascular axis in diabetes: exploring impaired blood flow, cardiovascular disease, and peripheral arterial complications. International Journal of Research in Medical Sciences 2025; 13(10): 4518 doi: 10.18203/2320-6012.ijrms20253215
|